Share on LinkedInShare on LinkedIn

ARTICLE · 10 NOVEMBER 2022

ONC And OSTP Request Information For Operationalizing Interoperability In Clinical Trial

BakerHostetler
BakerHostetler
Contributor
BakerHostetler

BakerHostetler

Recognized as an innovator and one of the top firms for client service, BakerHostetler helps...

View firm profile
Explore more from BakerHostetler

In response to the COVID-19 pandemic, the Biden administration recently announced its National Biodefense Strategy aimed at national preparedness for biological threats.

United StatesMedia, Telecoms, IT, Entertainment

Key Takeaways

  • In response to the COVID-19 pandemic, the White House Office of Science & Technology Policy and the Office of the National Coordinator for Health Information Technology take a major step towards testing interoperability capabilities in clinical trials.
  • The regulatory and technological framework for the interoperability of Electronic Health Records platforms could be applied to the clinical trials context.
  • Shift towards the use of interoperable technologies could improve the collection and exchange of clinical trials data between institutions in emergent and non-emergent settings.

In response to the COVID-19 pandemic, the Biden administration recently announced its National Biodefense Strategy aimed at national preparedness for biological threats. The National Biodefense Strategy sets several targets for improved capabilities in order to respond to biologic threats – such as a pandemic – including "maintaining clinical trial infrastructure

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from